Silk Road Medical (SILK) came out with a quarterly loss of $0.42 per share versus the Zacks Consensus Estimate of a loss of $0.38. This compares to loss of $0.35 per share a year ago.
Silk Road Medical (SILK) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.
Silk stock skyrocketed Tuesday after Boston Scientific agreed to buy the medical devices company for $1.16 billion.
Silk Road Medical (NASDAQ: SILK ) stock is on the rise Tuesday after the medical device company announced an acquisition deal with Boston Scientific (NYSE: BSX ). This deal has Boston Scientific agreeing to acquire shares of SILK stock for $27.50 each in cash.
Silk Road Medical Inc.'s stock SILK, +1.31% was up 22.6% in pre-market trades on Tuesday after it agreed to be acquired by Boston Scientific Corp. BSX, -0.74% for $27.50 a share. The deal values the medical device company at just under $1.2 billion.